Antonio Caos

Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States

Alimentary Pharmacology & Therapeutics · 2005 · First of 4 authors · Corresponding

Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group

The American Journal of Gastroenterology · 2000 · First of 6 authors